Histoplasmosis & endemic mycoses
Endemic fungi · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Endemic dimorphic fungi (Histoplasma, Blastomyces, Coccidioides, Talaromyces) cause pulmonary and, in the immunosuppressed, disseminated disease after travel/residence in endemic areas. Severity dictates amphotericin induction versus oral azole.
Red flags
- Respiratory failure or ARDS
- Disseminated disease with sepsis in HIV
- CNS involvement (meningitis)
- Adrenal insufficiency (histoplasmosis)
- Rapid deterioration
Assessment
Differential diagnosis
- Tuberculosis
- Sarcoidosis
- Community-acquired pneumonia
- Malignancy/lymphoma
- Other opportunistic infection in HIV
Investigations
- Travel/residence history for endemic exposure
- Fungal culture and histopathology of tissue/respiratory samples
- Histoplasma urine/serum antigen (and other antigen tests)
- CT chest; imaging of disseminated sites
- HIV test and CD4
- Serology where appropriate (e.g. coccidioidomycosis)
Management
- Take a detailed travel/residence and exposure history
- Obtain antigen testing, cultures and histology from affected sites
- Assess severity and immune status (disseminated disease in HIV/immunosuppressed)
- Treat mild, self-limited pulmonary disease with observation or oral azole
- Start liposomal amphotericin B induction for severe/disseminated disease
- Step down to oral itraconazole (histoplasmosis/blastomycosis) after improvement
- Use fluconazole for coccidioidal meningitis (lifelong) per type
- Monitor azole levels (itraconazole) and liver function
- In HIV, start ART with attention to IRIS
- Give prolonged therapy and secondary prophylaxis where immunosuppression persists
- Watch for relapse with antigen monitoring
- Specialist ID follow-up
Drugs & doses
Liposomal amphotericin B 3 mg/kg IV daily (5 mg/kg for CNS) for severe/disseminated induction
Itraconazole 200 mg PO three times daily for 3 days then twice daily (histoplasmosis/blastomycosis)
Fluconazole 400-800 mg PO daily (coccidioidomycosis; lifelong for meningitis)
Itraconazole maintenance with therapeutic drug monitoring
Disposition
Admit for severe/disseminated disease; outpatient oral azole for mild; ID follow-up.
Complications & pitfalls
- Disseminated multi-organ disease
- Chronic cavitary pulmonary disease
- CNS infection and hydrocephalus
- Adrenal insufficiency
- Relapse / IRIS in HIV
Exam pearls
- Geography is key - ask where the patient has lived/travelled
- Urine Histoplasma antigen is useful for rapid diagnosis of disseminated disease
- Itraconazole requires therapeutic drug monitoring; absorption is variable
- Coccidioidal meningitis needs lifelong fluconazole
- Consider in HIV patients with unexplained disseminated illness from endemic regions
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.